Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
Prostate Cancer, Prostate Cancer, Familial, Hereditary Prostate Cancer
About this trial
This is an interventional basic science trial for Prostate Cancer focused on measuring Genetic testing, Genomic testing, Chemoprevention, Prostate Specific Antigen, Prostate Cancer, Predictive Genetic Testing, Genetic Counseling, Prostate-Specific Antigen
Eligibility Criteria
Inclusion Criteria:
- age 40 to 49 years, self-defined Caucasian background, and no prior prostate specific antigen (PSA) screening nor prostate cancer (PCa) diagnosis.
Exclusion Criteria:
- outside of age range, or not self defined Caucasian background, or a prior history of PSA screening or PCa diagnosis
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Genetic Risk Score: Number Format
Genetic Risk Score: Number + Pictograph
Family History: Number Format
Family History: Number + Pictograph
Genetic Risk Score: Number Format Subjects receive genetic risk scores in a number format.
Genetic Risk Score: Number + Pictograph Subjects receive genetic risk scores in a number and pictograph format.
Family History: Number Format Subjects receive family history risk in a number format.
Family History: Number + Pictograph Subjects receive family history risk in a number and pictograph format.